June 26, 2026 a 08:38 am
COO: Analysts Ratings - The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) remains a key player in the global medical device sector, offering a diverse range of products through its CooperVision and CooperSurgical units. The ongoing analyst ratings showcase steady confidence, evidenced by consistent "Buy" and "Hold" recommendations. As the company continues to innovate within the optical and women's health domains, it appears well-positioned for sustained growth.
Historical Stock Grades
Recent analyst ratings for The Cooper Companies, Inc. reflect a stable outlook with a predominant inclination towards "Buy" and "Hold". As of June 2026, the ratings are as follows:
| Rating | Number of Recommendations | Score |
|---|---|---|
| Strong Buy | 4 | |
| Buy | 6 | |
| Hold | 5 | |
| Sell | 1 | |
| Strong Sell | 0 |
Sentiment Development
The overall sentiment towards The Cooper Companies, Inc. has shown a shift over the months with minor fluctuations in the number of ratings in each category.
- The number of "Strong Buy" recommendations has slightly decreased in recent months, indicating a cautious optimism among analysts.
- "Buy" ratings have remained relatively stable, suggesting sustained confidence in future performance.
- The tendency towards "Hold" ratings suggests a balanced perspective on current valuation levels.
Percentage Trends
Analyzing the percentage distribution provides insights into potential shifts in analyst perspectives:
- "Strong Buy" ratings have comprised approximately 30% of all recommendations but have recently seen a slight decline.
- The percentage of "Hold" ratings has increased, reflecting more caution or neutrality.
- The "Buy" category remains the strongest, occupying about 40% of the sentiment share indicative of a positive outlook.
- Over the past year, a clear trend towards more conservative assessments is notable as caution appears to rise amid potential market uncertainties.
Latest Analyst Recommendations
The following table summarizes the latest analyst recommendations from the past week:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-06-08 | Outperform | Outperform | BNP Paribas |
| 2026-06-05 | Outperform | Outperform | Baird |
| 2026-06-05 | Neutral | Neutral | JP Morgan |
| 2026-06-05 | Buy | Buy | Needham |
| 2026-06-05 | Buy | Buy | Stifel |
Analyst Recommendations with Change of Opinion
Instances of shifts in analyst opinions over the past year are outlined below:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-13 | Equal Weight | Overweight | Wells Fargo |
| 2025-08-28 | Neutral | Buy | Citigroup |
| 2025-06-17 | Buy | Hold | Needham |
| 2025-05-30 | Neutral | Overweight | JP Morgan |
| 2024-03-13 | Overweight | Neutral | JP Morgan |
Interpretation
The current analyst sentiments about The Cooper Companies, Inc. emphasize a cautious optimism, suggesting that the company is postured for steady growth despite some emerging uncertainties. The prevalence of "Hold" and "Buy" ratings highlights confidence in the company's fundamentals, yet the decrease in "Strong Buy" ratings from previous months underlines a growing conservative stance perhaps due to market volatility. This cautious approach indicates a stable yet watchful outlook, as analysts appear divided between maintaining current expectations and hedging against possible slower growth.
Conclusion
The Cooper Companies, Inc. continues to exhibit a robust position in the healthcare sector, backed by substantial product diversity and innovation. Despite a slight dip in "Strong Buy" ratings, the consistency in "Buy" and "Hold" recommendations underscores solid confidence among analysts. The observed sentiment change points to a balance between optimism for steady growth and prudence amidst potential market shifts. Analysts' views signal both potential for appreciation and an acknowledgment of market challenges, reinforcing the importance of closely monitoring subsequent performance trends.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years